How Autoimmune Diseases Work: The Mechanism Behind Immune-System Misfires

Having a first-degree relative with an autoimmune disease increases your risk roughly 3-5 times over the general population for the same disease, and modestly increases risk for other autoimmune diseases too, because many share genetic markers in the HLA (major histocompatibility complex) region. But most people with family history never develop an autoimmune disease, and most autoimmune-disease patients have no clear family history. Practical implications: family history is a risk multiplier, not a diagnosis. If you have a first-degree relative with RA, lupus, type 1 diabetes, MS, celiac disease, or autoimmune thyroid disease, be alert for symptoms in yourself, persistent joint pain, unexplained fatigue, thyroid changes, unexplained rashes, and get autoimmune blood-panel testing at first symptoms rather than assuming stress. Female sex is a stronger risk factor than family history for many autoimmune diseases; women account for roughly 80% of autoimmune disease cases.

Two main mechanisms explain the infection-autoimmune link. First, molecular mimicry: some pathogens produce proteins that structurally resemble the body's own proteins. When the immune system attacks the pathogen, it can accidentally attack similar-looking self-proteins, a well-documented example is rheumatic fever after streptococcal throat infection, where anti-strep antibodies cross-react with heart valve tissue. Second, tissue damage from infection can expose 'hidden' self-antigens (proteins normally shielded from immune surveillance) to immune cells, triggering an autoimmune response. Well-studied examples: viral infections triggering type 1 diabetes onset in genetically susceptible children, Epstein-Barr virus infection increasing multiple sclerosis risk, and various infections triggering lupus flares. This does not mean infections cause autoimmune disease in most people, genetic susceptibility must be present, but they are common triggering events in people already at risk.

Common autoimmune blood tests widely available in Indian labs: ANA (antinuclear antibody), a general screening test; RF (rheumatoid factor) and anti-CCP, for rheumatoid arthritis; anti-dsDNA and anti-Smith, more specific for lupus; TSH plus anti-TPO and anti-thyroglobulin, for autoimmune thyroid disease (Hashimoto's, Graves'); tissue transglutaminase (tTG), for celiac disease; ESR and CRP, general inflammation markers, non-specific but useful for tracking disease activity. Ask for autoimmune screening if you have: persistent joint pain lasting more than 6 weeks, unexplained fatigue lasting weeks, unexplained skin rashes especially with sun sensitivity, thyroid symptoms (weight change, temperature intolerance, fatigue), or family history of autoimmune disease plus any suggestive symptoms. Results always need interpretation by a doctor, many people have low-positive ANA without any autoimmune disease, and the pattern of positives (which specific antibodies) matters more than any single test.

Most autoimmune diseases cannot be cured currently but can be managed effectively, often to the point of clinical remission with minimal symptoms. Modern treatment falls into three categories: (a) immunosuppressive medications that dampen the overactive immune response (steroids for acute flares, methotrexate and other DMARDs for long-term control); (b) biologic drugs that target specific parts of the immune response (adalimumab, rituximab, tocilizumab for RA and lupus; interferons for MS); (c) replacement therapy for damaged tissues (insulin for type 1 diabetes, thyroxine for Hashimoto's, vitamin D for related deficiencies). Sustained remission is now achievable for many patients with early aggressive treatment, particularly RA and inflammatory bowel disease. Lifestyle factors, quitting smoking, stress management, adequate sleep, anti-inflammatory diet, meaningfully improve outcomes alongside medication. Ongoing research into immune-tolerance therapies aims for actual cure but is not yet standard practice.